Organizing Committee Member
Huamin Wang
Professor
University of Texas MD Anderson Cancer Center
USA
Biography
Dr. Wang received his M.D. from Tongji Medical College, Huazhong University of Science & Technology in 1987 and his Ph.D. in Biochemistry & Molecular Biology from the University of Texas (UT) Graduate School of Biomedical Sciences (Houston, TX) in 1999. He did his residency at the UT Medical School (Houston) from 1999 to 2003 and his fellowship in Selective Surgical Pathology at UT MD Anderson Cancer Center (MDACC) from 2003 to 2004. In July 2004, Dr. Wang joined the Department of Pathology at MDACC as an assistant professor specialized in gastrointestinal, liver and pancreatic pathology. He is currently a tenured professor of pathology with joint appointment as a professor in the Department of Translational Molecular Pathology (MDACC) and at UT Graduate School of Biomedical Sciences in Houston. Dr. Wang is the co-director of pancreatic cancer tumor bank and serves as the Scientific Advisory Board member for the Sheikh Ahmed Center for Pancreatic Cancer Research at UTMDACC. Dr. Wang is well recognized in the field of GI and pancreaticobiliary pathology and in clinical/translational research of pancreatic cancer. His major research interests are focused on tumor biology, animal models, tumor markers for early detection, prognosis, and treatment for pancreatic cancer. Dr. Wang has served as principle investigator (PI), pathology core leaders, co-PI, or co-investigator for more than 35 research grants including NIH/NCI Specialized Program of Research Excellence (SPORE) on pancreatic cancer, P01s, U01, R01s, K08, R21s and the Moonshot Program on pancreatic cancer at MDACC. Dr. Wang has authored more than 200 peer-reviewed publications in prestigious journals including Nature, Cell, Nature Communications, Cancer Cell, Journal of Clinical Oncology, Proceedings of National Academy of Sciences USA, Gastroenterology, Journal of Clinical Investigation etc., 12 invited review articles and 9 book chapters. He is serving as the editors for 12 prestigious scientific journals and as an ad hoc reviewer for 34 journals. He received many awards for his research, including the Career Development Award from the American Association for Cancer Research. As an expert in GI pathology, he was selected to serve on the American Joint Committee on Cancer (AJCC) Foregut Task Force for the 7th edition of the AJCC Cancer Staging Manual. Dr. Wang was the President of the Chinese American Pathologists Association (CAPA) 2016-2017, which is the largest organization in North America for the pathologists who cherish Chinese culture. Under his strong leadership, CAPA membership grew 42% from 510 to 725 in one year. Dr. Wang is a member of the Publications Committee and a member of the Ramzi S. Cotran Young Investigator Award Committee of the United States and Canadian Academy of Pathology (USCAP).
Research Area
Clinical/translational research of pancreatic cancer